In a growing global trend, bacteria are evolving new ways to maneuver around medical treatments for a variety of infections.

Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing ...

Scientists are now looking to bacteriophage — viruses that infect bacteria — and their potential to treat drug-resistant ...

The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by ...

This study provides proof-of-principle data for the use of trained immunity to modulate macrophage interactions with tumours. The study makes a valuable contribution to the field of trained immunity.

Your period is just one part of a four-phase cycle that affects your mood, energy and even your mental clarity all month long ...

Researchers at the FAMU-FSU College of Engineering have developed a novel method for investigating protein degradation in immune cells.

FAMU-FSU College of Engineering researchers have created a new method for studying protein degradation within immune cells ...

As we observe Endometriosis Awareness Month in March, let us take a look at 7 biotech companies advancing promising ...

MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today the launch of Minjuvi ® ...

Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced an abstract on AFM24 dose optimization ...